Use the search parameters below to filter talks:

2013 - IXA 2013 Congress (Osaka)

Oral Communication: Clinical(1) Kidney TX
10 November 2013  /  17:15 - 18:20
Outcomes of ABO-Incompatible Living-donor Kidney Transplantation
Presenter: Masashi Takenaka, Japan

Oral Communication: Clinical (2)
10 November 2013  /  18:20 - 19:00
Expression of ABO (ABH) histo-blood group antigens in the normal lungs and chimerism in the explanted lungs after ABO incompatible hematopoietic stem cell transplantation.
Presenter: Kyoko Hijiya, Japan
Long-term evaluation of ABO antibodies after allogeneic ABO incompatible hematopoietic stem cell transplantation
Presenter: Gisella Puga Yung, Switzerland

Early Morning Educational Lecture 1: Differences between anti-HLA Abs and anti-carbohydrate Abs (Main Room)
11 November 2013  /  07:30 - 09:00
The different sensitivity of B cells responding to carbohydrate and HLA antigens to immunosuppressants
Presenter: Hideki Ohdan, Japan
Anti-HLA Ab
Presenter: Michael Rees, United States
Accommodation: Lessen from clinical cases
Presenter: Kazuhide Saito, Japan

Joint Plenary Session: How can we overcome Immune Responses associated with Presensitization? - Optimal Regimen, Accommodation and B-Cell Tolerance
11 November 2013  /  09:30 - 12:30
Current optimal regimens in iABO transplantation
Presenter: Kazunari Tanabe, Japan
Modification of B-cells in Alloimmunity
Presenter: Stanley Jordan, United States
Diagnostic challenges in chronic antibody-mediated rejection
Presenter: Robert Colvin, United States
B cell tolerance
Presenter: Megan Sykes, United States

IXA Plenary Session 1: Update on Preclinical Life-Supporting Organ Xenotransplantation - Current Strategies to Remaining obstacles
11 November 2013  /  13:20 - 15:20
Kidney transplantation
Presenter: Kazuhiko Yamada, Japan
Liver transplantation
Presenter: Joseph Tector, United States
Lung xenotransplantation
Presenter: Richard N. Pierson III, United States

Oral Communication 1: Preclinical Solid Organs
11 November 2013  /  15:40 - 17:10
What progress has been made in pig-to-nonhuman primate transplantation models during the past 15 years? A retrospective review of the literature.
Presenter: David K.C. Cooper, United States
Combined CD40-CD154 / CD28-B7 costimulation blockade successfully replaces anti-CD154mAb in preventing a T cell response to genetically-engineered pig artery patch transplants in baboons
Presenter: Hayato Iwase, United States
Effect of Systemic Anti-154 (CD40L) Antibody on Clinical Outcomes of Full-thickness Porcine Corneal Graft in Pig-to-Rhesus Corneal Transplantation Model
Presenter: Hyuk Jin Choi, Korea
In vitro and in vivo testing of an anti-CD40mAb clone, 2C10, in xenotransplantation
Presenter: Hidetaka Hara, United States
Detection of Cytomegalovirus-related gastrointestinal tract lesions in a series of 45 xenotransplanted primates
Presenter: Laura Cavicchioli, Italy
Advances in a life-supporting xenogenic lung transplant model
Presenter: Lars Burdorf, United States
Over 9 Months Graft Survival Of GTKO.hCD46tg.hTMtg Pig Heterotopic Heart Xenograft In Anti CD40 (2C10) Treated Baboon
Presenter: Muhammad Mohiuddin, United States

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada

Info

Privacy Policy
Terms of Use
Copyright Notice